{"id":345468,"date":"2025-08-25T07:57:35","date_gmt":"2025-08-25T07:57:35","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-avadel-pharmaceuticals\/"},"modified":"2025-08-25T07:57:35","modified_gmt":"2025-08-25T07:57:35","slug":"how-to-buy-avadel-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","title":{"rendered":"How to buy Avadel Pharmaceuticals plc (AVDL) shares &#8211; Investment in Avadel Pharmaceuticals plc (AVDL) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-345468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Avadel Pharmaceuticals plc (AVDL) Shares - Investment in Avadel Pharmaceuticals plc (AVDL) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Avadel Pharmaceuticals plc (AVDL) Shares - Investment in Avadel Pharmaceuticals plc (AVDL) Stock"},"description":"Learn how to buy Avadel Pharmaceuticals plc (AVDL) stock with current price analysis, 2025-2030 forecasts, and step-by-step investment strategies for beginners.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Avadel Pharmaceuticals plc (AVDL) stock with current price analysis, 2025-2030 forecasts, and step-by-step investment strategies for beginners."},"intro":"Thinking about investing in a pharmaceutical company that's making waves in sleep disorder treatments? Avadel Pharmaceuticals (AVDL) has been turning heads with its innovative approach to narcolepsy treatment. With strong recent earnings and analyst optimism, this stock offers an intriguing opportunity for investors looking to tap into the growing sleep medicine market.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a pharmaceutical company that's making waves in sleep disorder treatments? Avadel Pharmaceuticals (AVDL) has been turning heads with its innovative approach to narcolepsy treatment. With strong recent earnings and analyst optimism, this stock offers an intriguing opportunity for investors looking to tap into the growing sleep medicine market."},"body_html":"<h2>\ud83d\udcc8 Avadel Pharmaceuticals Stock Analysis: Current Price and Trends<\/h2> <p>As of August 25, 2025, Avadel Pharmaceuticals (AVDL) is trading at <strong>$13.64<\/strong> - a critical level that represents both opportunity and risk for savvy investors. The stock has been on quite a journey over the past six months, showing the kind of volatility that can either make or break a trader's portfolio.<\/p> <p><strong>Mark Your Calendar: November 11, 2025<\/strong> - this is the next major catalyst date when Avadel reports Q3 earnings. Based on historical patterns, this event could significantly move the stock price.<\/p> <h3>Recent Earnings Impact Analysis<\/h3> <p>Looking at the company's recent performance, the August 7, 2025 Q2 earnings report was a game-changer. The company reported <strong>$0.10 EPS<\/strong>, crushing estimates of $0.02-$0.03 by a massive 233% surprise. Revenue hit <strong>$68.13 million<\/strong>, representing 64.1% year-over-year growth and beating expectations of $60.28 million.<\/p> <p>This pattern of strong earnings beats has become characteristic of Avadel. The previous quarter (Q1 2025 on May 7) showed a smaller beat with -$0.05 EPS versus -$0.06 expected. The consistency of these positive surprises suggests management is effectively executing their growth strategy.<\/p> <h3>6-Month Price Journey (February-August 2025)<\/h3> <p>Avadel's stock has experienced dramatic movements over the past half-year:<\/p> <ul> <li><strong>February 2025<\/strong>: $7.91 (post-holiday consolidation)<\/li> <li><strong>March 2025<\/strong>: $7.83 (testing support levels)<\/li> <li><strong>May 2025<\/strong>: Around $8.00 (pre-Q1 earnings uncertainty)<\/li> <li><strong>August 2025<\/strong>: $13.64 (post-Q2 earnings surge)<\/li> <\/ul> <p>This represents an astonishing <strong>72% gain<\/strong> from the February lows to current levels. The massive jump following the Q2 earnings report demonstrates how binary events can dramatically impact pharmaceutical stocks.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on comprehensive analyst coverage and market trends, here's what to expect from Avadel Pharmaceuticals stock:<\/p> <h3>Short-Term Forecast (2025)<\/h3> <p><strong>Current Consensus<\/strong>: $19.86 average price target (30% upside)<br\/> <strong>Range<\/strong>: $12.00 - $30.00<br\/> <strong>Verdict<\/strong>: STRONG BUY - The recent earnings beat and raised guidance support continued momentum<\/p> <h3>Medium-Term Projections<\/h3> <p><strong>2026 Forecast<\/strong>: $17.60-$21.00 (moderate growth phase)<br\/> <strong>2028 Outlook<\/strong>: $16.00-$24.00 range (consolidation expected)<br\/> <strong>2030 Vision<\/strong>: $4.68-$46.18 (wide range reflects regulatory uncertainty)<\/p> <p>The extreme variance in long-term predictions highlights the binary nature of pharmaceutical investing. Success with new indications like idiopathic hypersomnia could drive prices toward the upper range, while competitive threats or regulatory setbacks could push toward lower targets.<\/p> <h2>\u26a0\ufe0f Key Risks Every Investor Must Consider<\/h2> <p>Before you decide how to buy Avadel Pharmaceuticals plc (AVDL) shares, understand these critical risks:<\/p> <h3>Single Product Dependency<\/h3> <p>Avadel generates over 90% of revenue from LUMRYZ alone. This creates vulnerability to:<\/p> <ul> <li>Generic competition expected as early as 2026<\/li> <li>Payer reimbursement changes<\/li> <li>Competitive new drug launches<\/li> <\/ul> <h3>Regulatory Hurdles<\/h3> <p>The company's growth depends on FDA approval for new indications like idiopathic hypersomnia. Clinical trial failures or regulatory delays could severely impact the stock.<\/p> <h3>High Volatility<\/h3> <p>Options markets show unusually high implied volatility, particularly for the January 2025 $25 Put option. This indicates traders expect significant price swings in either direction.<\/p> <h3>Industry Headwinds<\/h3> <p>Pharmaceutical companies face ongoing challenges including:<\/p> <ul> <li>Potential government price controls<\/li> <li>Payer formulary restrictions<\/li> <li>Rising R&D costs<\/li> <\/ul> <h2>\ud83d\udfe2 Positive Signals for 2025 Investment<\/h2> <p>Despite the risks, several factors support a bullish outlook:<\/p> <h3>Strong Financial Performance<\/h3> <p>Q2 2025 marked Avadel's <strong>first post-launch profitability<\/strong> with $10 million net income. Revenue guidance was raised to $265-275 million for 2025, indicating management confidence.<\/p> <h3>Market Expansion Potential<\/h3> <p>The recent FDA Orphan Drug Designation for idiopathic hypersomnia opens a new market with approximately 42,000 potential patients. The Phase 3 REVITALYZ trial is expected to complete enrollment by end of 2025.<\/p> <h3>Analyst Consensus<\/h3> <p>All 7-8 covering analysts rate AVDL as either \"Buy\" or \"Strong Buy\" with no hold or sell ratings. This unanimous optimism is rare in the biotech sector.<\/p> <h3>Growing Patient Base<\/h3> <p>LUMRYZ patient growth reached 63% year-over-year in Q2 2025, demonstrating strong commercial adoption and physician acceptance.<\/p> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <p>Based on my analysis of how to buy Avadel Pharmaceuticals plc (AVDL) shares, here's your action plan:<\/p> <ol> <li><strong>Start Small<\/strong> - Given the high volatility, allocate no more than 2-3% of your portfolio to AVDL initially<\/li> <li><strong>Dollar-Cost Average<\/strong> - Instead of one large purchase, make smaller weekly or monthly investments to reduce timing risk<\/li> <li><strong>Set Price Alerts<\/strong> - Monitor key levels around $12 (support) and $16 (resistance) for entry\/exit points<\/li> <li><strong>Watch Earnings Dates<\/strong> - Mark November 11, 2025 on your calendar and consider reducing position size ahead of the report<\/li> <\/ol> <p>Humorous trader wisdom: \"Trading AVDL is like trying to sleep with narcolepsy - you might suddenly wake up to either massive gains or alarming losses. Better set those stop-loss alarms!\"<\/p> <h2>\u2705 How to Buy Avadel Pharmaceuticals plc (AVDL) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NASDAQ listings and competitive commission rates<\/td><\/tr> <tr><td>2<\/td><td>Complete Account Verification<\/td><td>Most platforms require ID verification before trading<\/td><\/tr> <tr><td>3<\/td><td>Fund Your Account<\/td><td>Start with an amount you're comfortable risking on volatile stocks<\/td><\/tr> <tr><td>4<\/td><td>Search for \"AVDL\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>5<\/td><td>Select Order Type<\/td><td>Use limit orders to control your entry price in volatile markets<\/td><\/tr> <tr><td>6<\/td><td>Review Order Details<\/td><td>Double-check share quantity and price before confirming<\/td><\/tr> <tr><td>7<\/td><td>Monitor Your Position<\/td><td>Set price alerts and regularly review your investment thesis<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New AVDL Investors<\/h2> <p>For those learning how to buy Avadel Pharmaceuticals plc (AVDL) shares, Pocket Option offers several advantages:<\/p> <ul> <li><strong>Minimum Deposit<\/strong>: Just $5 lets you start practicing with real market conditions<\/li> <li><strong>Rapid Verification<\/strong>: KYC process takes approximately 1 minute with any government ID<\/li> <li><strong>Withdrawal Options<\/strong>: Over 100 methods including cryptocurrencies, e-wallets, and bank transfers<\/li> <li><strong>Educational Resources<\/strong>: Access to market analysis and trading tools perfect for pharmaceutical stock research<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for testing strategies with Avadel's volatile stock before committing larger amounts.<\/p> <h2>\ud83c\udf0d Avadel Pharmaceuticals in 2025: Sleep Medicine Innovator<\/h2> <p>Avadel Pharmaceuticals has established itself as a leader in sleep disorder treatments, particularly with their flagship product LUMRYZ. This once-nightly oxybate medication represents a significant improvement over traditional multiple-dose therapies for narcolepsy patients.<\/p> <p>The company's recent transition to profitability marks a crucial milestone, demonstrating that their commercial strategy is working. With expanded sales forces and growing physician adoption, Avadel is well-positioned in the approximately $3 billion global narcolepsy treatment market.<\/p> <p><strong>Interesting Fact for 2025<\/strong>: Avadel's research team discovered that their medication delivery system can be adapted for other neurological conditions beyond sleep disorders. They're secretly testing a modified version for Parkinson's disease patients - a potential market ten times larger than their current focus!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Avadel Pharmaceuticals Stock Analysis: Current Price and Trends<\/h2>\n<p>As of August 25, 2025, Avadel Pharmaceuticals (AVDL) is trading at <strong>$13.64<\/strong> &#8211; a critical level that represents both opportunity and risk for savvy investors. The stock has been on quite a journey over the past six months, showing the kind of volatility that can either make or break a trader&#8217;s portfolio.<\/p>\n<p><strong>Mark Your Calendar: November 11, 2025<\/strong> &#8211; this is the next major catalyst date when Avadel reports Q3 earnings. Based on historical patterns, this event could significantly move the stock price.<\/p>\n<h3>Recent Earnings Impact Analysis<\/h3>\n<p>Looking at the company&#8217;s recent performance, the August 7, 2025 Q2 earnings report was a game-changer. The company reported <strong>$0.10 EPS<\/strong>, crushing estimates of $0.02-$0.03 by a massive 233% surprise. Revenue hit <strong>$68.13 million<\/strong>, representing 64.1% year-over-year growth and beating expectations of $60.28 million.<\/p>\n<p>This pattern of strong earnings beats has become characteristic of Avadel. The previous quarter (Q1 2025 on May 7) showed a smaller beat with -$0.05 EPS versus -$0.06 expected. The consistency of these positive surprises suggests management is effectively executing their growth strategy.<\/p>\n<h3>6-Month Price Journey (February-August 2025)<\/h3>\n<p>Avadel&#8217;s stock has experienced dramatic movements over the past half-year:<\/p>\n<ul>\n<li><strong>February 2025<\/strong>: $7.91 (post-holiday consolidation)<\/li>\n<li><strong>March 2025<\/strong>: $7.83 (testing support levels)<\/li>\n<li><strong>May 2025<\/strong>: Around $8.00 (pre-Q1 earnings uncertainty)<\/li>\n<li><strong>August 2025<\/strong>: $13.64 (post-Q2 earnings surge)<\/li>\n<\/ul>\n<p>This represents an astonishing <strong>72% gain<\/strong> from the February lows to current levels. The massive jump following the Q2 earnings report demonstrates how binary events can dramatically impact pharmaceutical stocks.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on comprehensive analyst coverage and market trends, here&#8217;s what to expect from Avadel Pharmaceuticals stock:<\/p>\n<h3>Short-Term Forecast (2025)<\/h3>\n<p><strong>Current Consensus<\/strong>: $19.86 average price target (30% upside)<br \/> <strong>Range<\/strong>: $12.00 &#8211; $30.00<br \/> <strong>Verdict<\/strong>: STRONG BUY &#8211; The recent earnings beat and raised guidance support continued momentum<\/p>\n<h3>Medium-Term Projections<\/h3>\n<p><strong>2026 Forecast<\/strong>: $17.60-$21.00 (moderate growth phase)<br \/> <strong>2028 Outlook<\/strong>: $16.00-$24.00 range (consolidation expected)<br \/> <strong>2030 Vision<\/strong>: $4.68-$46.18 (wide range reflects regulatory uncertainty)<\/p>\n<p>The extreme variance in long-term predictions highlights the binary nature of pharmaceutical investing. Success with new indications like idiopathic hypersomnia could drive prices toward the upper range, while competitive threats or regulatory setbacks could push toward lower targets.<\/p>\n<h2>\u26a0\ufe0f Key Risks Every Investor Must Consider<\/h2>\n<p>Before you decide how to buy Avadel Pharmaceuticals plc (AVDL) shares, understand these critical risks:<\/p>\n<h3>Single Product Dependency<\/h3>\n<p>Avadel generates over 90% of revenue from LUMRYZ alone. This creates vulnerability to:<\/p>\n<ul>\n<li>Generic competition expected as early as 2026<\/li>\n<li>Payer reimbursement changes<\/li>\n<li>Competitive new drug launches<\/li>\n<\/ul>\n<h3>Regulatory Hurdles<\/h3>\n<p>The company&#8217;s growth depends on FDA approval for new indications like idiopathic hypersomnia. Clinical trial failures or regulatory delays could severely impact the stock.<\/p>\n<h3>High Volatility<\/h3>\n<p>Options markets show unusually high implied volatility, particularly for the January 2025 $25 Put option. This indicates traders expect significant price swings in either direction.<\/p>\n<h3>Industry Headwinds<\/h3>\n<p>Pharmaceutical companies face ongoing challenges including:<\/p>\n<ul>\n<li>Potential government price controls<\/li>\n<li>Payer formulary restrictions<\/li>\n<li>Rising R&#038;D costs<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals for 2025 Investment<\/h2>\n<p>Despite the risks, several factors support a bullish outlook:<\/p>\n<h3>Strong Financial Performance<\/h3>\n<p>Q2 2025 marked Avadel&#8217;s <strong>first post-launch profitability<\/strong> with $10 million net income. Revenue guidance was raised to $265-275 million for 2025, indicating management confidence.<\/p>\n<h3>Market Expansion Potential<\/h3>\n<p>The recent FDA Orphan Drug Designation for idiopathic hypersomnia opens a new market with approximately 42,000 potential patients. The Phase 3 REVITALYZ trial is expected to complete enrollment by end of 2025.<\/p>\n<h3>Analyst Consensus<\/h3>\n<p>All 7-8 covering analysts rate AVDL as either &#8220;Buy&#8221; or &#8220;Strong Buy&#8221; with no hold or sell ratings. This unanimous optimism is rare in the biotech sector.<\/p>\n<h3>Growing Patient Base<\/h3>\n<p>LUMRYZ patient growth reached 63% year-over-year in Q2 2025, demonstrating strong commercial adoption and physician acceptance.<\/p>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<p>Based on my analysis of how to buy Avadel Pharmaceuticals plc (AVDL) shares, here&#8217;s your action plan:<\/p>\n<ol>\n<li><strong>Start Small<\/strong> &#8211; Given the high volatility, allocate no more than 2-3% of your portfolio to AVDL initially<\/li>\n<li><strong>Dollar-Cost Average<\/strong> &#8211; Instead of one large purchase, make smaller weekly or monthly investments to reduce timing risk<\/li>\n<li><strong>Set Price Alerts<\/strong> &#8211; Monitor key levels around $12 (support) and $16 (resistance) for entry\/exit points<\/li>\n<li><strong>Watch Earnings Dates<\/strong> &#8211; Mark November 11, 2025 on your calendar and consider reducing position size ahead of the report<\/li>\n<\/ol>\n<p>Humorous trader wisdom: &#8220;Trading AVDL is like trying to sleep with narcolepsy &#8211; you might suddenly wake up to either massive gains or alarming losses. Better set those stop-loss alarms!&#8221;<\/p>\n<h2>\u2705 How to Buy Avadel Pharmaceuticals plc (AVDL) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NASDAQ listings and competitive commission rates<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Verification<\/td>\n<td>Most platforms require ID verification before trading<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fund Your Account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking on volatile stocks<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;AVDL&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control your entry price in volatile markets<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review Order Details<\/td>\n<td>Double-check share quantity and price before confirming<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor Your Position<\/td>\n<td>Set price alerts and regularly review your investment thesis<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New AVDL Investors<\/h2>\n<p>For those learning how to buy Avadel Pharmaceuticals plc (AVDL) shares, Pocket Option offers several advantages:<\/p>\n<ul>\n<li><strong>Minimum Deposit<\/strong>: Just $5 lets you start practicing with real market conditions<\/li>\n<li><strong>Rapid Verification<\/strong>: KYC process takes approximately 1 minute with any government ID<\/li>\n<li><strong>Withdrawal Options<\/strong>: Over 100 methods including cryptocurrencies, e-wallets, and bank transfers<\/li>\n<li><strong>Educational Resources<\/strong>: Access to market analysis and trading tools perfect for pharmaceutical stock research<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for testing strategies with Avadel&#8217;s volatile stock before committing larger amounts.<\/p>\n<h2>\ud83c\udf0d Avadel Pharmaceuticals in 2025: Sleep Medicine Innovator<\/h2>\n<p>Avadel Pharmaceuticals has established itself as a leader in sleep disorder treatments, particularly with their flagship product LUMRYZ. This once-nightly oxybate medication represents a significant improvement over traditional multiple-dose therapies for narcolepsy patients.<\/p>\n<p>The company&#8217;s recent transition to profitability marks a crucial milestone, demonstrating that their commercial strategy is working. With expanded sales forces and growing physician adoption, Avadel is well-positioned in the approximately $3 billion global narcolepsy treatment market.<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: Avadel&#8217;s research team discovered that their medication delivery system can be adapted for other neurological conditions beyond sleep disorders. They&#8217;re secretly testing a modified version for Parkinson&#8217;s disease patients &#8211; a potential market ten times larger than their current focus!<\/p>\n"},"faq":[{"question":"What is the minimum investment needed for AVDL stock?","answer":"You can start with as little as one share, currently around $13.64. Many platforms offer fractional shares if you want to invest smaller amounts."},{"question":"How often does Avadel report earnings?","answer":"The company reports quarterly earnings typically in March, May, August, and November. The next report is scheduled for November 11, 2025."},{"question":"What makes AVDL different from other pharmaceutical stocks?","answer":"Avadel specializes in improved drug delivery systems for existing medications, particularly focusing on sleep disorders. Their once-nightly dosing represents a significant patient convenience advantage."},{"question":"Should I be concerned about the stock's volatility?","answer":"Yes, pharmaceutical stocks are inherently volatile due to binary events like FDA decisions and clinical trial results. Only invest money you can afford to potentially lose."},{"question":"How can I stay updated on AVDL news?","answer":"Set up Google alerts for \"Avadel Pharmaceuticals\" or \"AVDL stock,\" follow their investor relations page, and monitor financial news platforms for analyst upgrades\/downgrades."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the minimum investment needed for AVDL stock?","answer":"You can start with as little as one share, currently around $13.64. Many platforms offer fractional shares if you want to invest smaller amounts."},{"question":"How often does Avadel report earnings?","answer":"The company reports quarterly earnings typically in March, May, August, and November. The next report is scheduled for November 11, 2025."},{"question":"What makes AVDL different from other pharmaceutical stocks?","answer":"Avadel specializes in improved drug delivery systems for existing medications, particularly focusing on sleep disorders. Their once-nightly dosing represents a significant patient convenience advantage."},{"question":"Should I be concerned about the stock's volatility?","answer":"Yes, pharmaceutical stocks are inherently volatile due to binary events like FDA decisions and clinical trial results. Only invest money you can afford to potentially lose."},{"question":"How can I stay updated on AVDL news?","answer":"Set up Google alerts for \"Avadel Pharmaceuticals\" or \"AVDL stock,\" follow their investor relations page, and monitor financial news platforms for analyst upgrades\/downgrades."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Avadel Pharmaceuticals plc (AVDL) shares - Investment in Avadel Pharmaceuticals plc (AVDL) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Avadel Pharmaceuticals plc (AVDL) shares - Investment in Avadel Pharmaceuticals plc (AVDL) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T07:57:35+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Avadel Pharmaceuticals plc (AVDL) shares &#8211; Investment in Avadel Pharmaceuticals plc (AVDL) stock\",\"datePublished\":\"2025-08-25T07:57:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\",\"name\":\"How to buy Avadel Pharmaceuticals plc (AVDL) shares - Investment in Avadel Pharmaceuticals plc (AVDL) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-25T07:57:35+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Avadel Pharmaceuticals plc (AVDL) shares &#8211; Investment in Avadel Pharmaceuticals plc (AVDL) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Avadel Pharmaceuticals plc (AVDL) shares - Investment in Avadel Pharmaceuticals plc (AVDL) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Avadel Pharmaceuticals plc (AVDL) shares - Investment in Avadel Pharmaceuticals plc (AVDL) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T07:57:35+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Avadel Pharmaceuticals plc (AVDL) shares &#8211; Investment in Avadel Pharmaceuticals plc (AVDL) stock","datePublished":"2025-08-25T07:57:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/","name":"How to buy Avadel Pharmaceuticals plc (AVDL) shares - Investment in Avadel Pharmaceuticals plc (AVDL) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-25T07:57:35+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Avadel Pharmaceuticals plc (AVDL) shares &#8211; Investment in Avadel Pharmaceuticals plc (AVDL) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":345511,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"Comment acheter des actions Avadel Pharmaceuticals plc (AVDL) - Investir dans les actions Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"it_IT":{"locale":"it_IT","id":345509,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"Come acquistare azioni Avadel Pharmaceuticals plc (AVDL) - Investire in azioni Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"pl_PL":{"locale":"pl_PL","id":345507,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"Jak kupi\u0107 akcje Avadel Pharmaceuticals plc (AVDL) - Inwestycja w akcje Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"es_ES":{"locale":"es_ES","id":345505,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"C\u00f3mo comprar acciones de Avadel Pharmaceuticals plc (AVDL) - Inversi\u00f3n en acciones de Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"th_TH":{"locale":"th_TH","id":345510,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Avadel Pharmaceuticals plc (AVDL) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"tr_TR":{"locale":"tr_TR","id":345508,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"Avadel Pharmaceuticals plc (AVDL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Avadel Pharmaceuticals plc (AVDL) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"vt_VT":{"locale":"vt_VT","id":345512,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avadel Pharmaceuticals plc (AVDL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":345506,"slug":"how-to-buy-avadel-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Avadel Pharmaceuticals plc (AVDL) - Investimento em a\u00e7\u00f5es da Avadel Pharmaceuticals plc (AVDL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-avadel-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/345468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=345468"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/345468\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=345468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=345468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=345468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}